Literature DB >> 15835900

Effects of chromogranin expression on inositol 1,4,5-trisphosphate-induced intracellular Ca2+ mobilization.

Yang Hoon Huh1, Soung Hoo Jeon, Jie Ae Yoo, Seon Young Park, Seung Hyun Yoo.   

Abstract

We show here that expression of chromogranins in non-neuroendocrine NIH3T3 cells significantly increased the amount of IP(3)-mediated intracellular Ca(2+) mobilization in these cells, whereas suppression of them in neuroendocrine PC12 cells decreased the amount of mobilized Ca(2+). We have therefore investigated the relationship between the IP(3)-induced intracellular Ca(2+) mobilization and secretory granules. The level of IP(3)-mediated Ca(2+) release in CGA-expressing NIH3T3 cells was 40% higher than in the control cells, while that of CGB-expressing cells was 134% higher, reflecting the number of secretory granules formed. Suppression of CGA and CGB expression in PC12 cells resulted in 41 and 78% reductions in the number of secretory granules, respectively, while the extents of IP(3)-induced Ca(2+) release in these cells were reduced 40 and 69%, respectively. The newly formed secretory granules of NIH3T3 cells contained all three isoforms of the IP(3)Rs. Comparison of the concentrations of the IP(3)R isoforms expressed in the ER and nucleus of chromogranin-expressing and nonexpressing NIH3T3 cells did not show significant differences, indicating that chromogranin expression did not affect the expression of endogenous IP(3)Rs. Nonetheless, the IP(3)R concentrations in secretory granules of chromogranin-expressing NIH3T3 cells were 3.5-4.7-fold higher than those of the ER, similar to the levels found in secretory granules of neuroendocrine chromaffin cells, thus suggesting that the IP(3)Rs targeted to the newly formed secretory granules are newly induced by chromogranins without affecting the expression of intrinsic IP(3)Rs. These results strongly suggest that the extent of IP(3)-induced intracellular Ca(2+) mobilization in secretory cells is closely related to the number of secretory granules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15835900     DOI: 10.1021/bi048070w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Inositol 1,4,5-trisphosphate receptor in chromaffin secretory granules and its relation to chromogranins.

Authors:  Seung Hyun Yoo; Yang Hoon Huh; Yong Suk Hur
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

2.  C-terminal domain of chromogranin B regulates intracellular calcium signaling.

Authors:  Stefan Schmidt; Michelle Mo; Felix M Heidrich; Andjelka Ćelić; Barbara E Ehrlich
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 3.  Secretory granules in inositol 1,4,5-trisphosphate-dependent Ca2+ signaling in the cytoplasm of neuroendocrine cells.

Authors:  Seung Hyun Yoo
Journal:  FASEB J       Date:  2009-10-16       Impact factor: 5.191

4.  Evidence for the existence of secretory granule (dense-core vesicle)-based inositol 1,4,5-trisphosphate-dependent Ca2+ signaling system in astrocytes.

Authors:  Yong Suk Hur; Ki Deok Kim; Sun Ha Paek; Seung Hyun Yoo
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

5.  Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.

Authors:  Felix M Heidrich; Kun Zhang; Manuel Estrada; Yan Huang; Frank J Giordano; Barbara E Ehrlich
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

6.  Functional Role of Intracellular Calcium Receptor Inositol 1,4,5-Trisphosphate Type 1 in Rat Hippocampus after Neonatal Anoxia.

Authors:  Juliane Midori Ikebara; Silvia Honda Takada; Débora Sterzeck Cardoso; Natália Myuki Moralles Dias; Beatriz Crossiol Vicente de Campos; Talitha Amanda Sanches Bretherick; Guilherme Shigueto Vilar Higa; Mariana Sacrini Ayres Ferraz; Alexandre Hiroaki Kihara
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.